iRhythm Technologies IRTC
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
iRhythm Technologies (IRTC) Core Market Data and Business Metrics
Latest Closing Price
$108.33Price-Earnings Ratio
-29.84Total Outstanding Shares
31.41 Million SharesDividend
No dividendSIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
NASDAQHeadquarters
699 8th Street, San Francisco, CA, 94103
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 464,882 Shares | 6.29 | 3/14/2025 | 2,924,295 Shares |
| 656,843 Shares | 4.49 | 2/28/2025 | 2,946,276 Shares |
| 353,777 Shares | 7.42 | 2/14/2025 | 2,625,133 Shares |
| 390,599 Shares | 6.21 | 1/31/2025 | 2,424,781 Shares |
| 477,529 Shares | 4.88 | 1/15/2025 | 2,330,046 Shares |
| 277,243 Shares | 8.07 | 12/31/2024 | 2,236,948 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities, Continuing | $-122.98 Million |
| Net Cash Flow From Operating Activities | $3.39 Million |
| Net Cash Flow From Financing Activities, Continuing | $511.38 Million |
| Net Cash Flow From Operating Activities, Continuing | $3.39 Million |
| Net Cash Flow From Investing Activities | $-122.98 Million |
| Net Cash Flow, Continuing | $391.79 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Selling, General, and Administrative Expenses | $418.56 Million |
| Costs And Expenses | $704.56 Million |
| Nonoperating Income/Loss | $2.78 Million |
| Diluted Earnings Per Share | $-3.63 |
| Income Tax Expense/Benefit, Current | $692,000 |
| Depreciation and Amortization | $20.71 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-113.01 Million |
| Comprehensive Income/Loss | $-113.01 Million |
| Other Comprehensive Income/Loss | $277,000 |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity | $90.91 Million |
| Cash | $317.18 Million |
| Inventory | $14.04 Million |
| Other Current Assets | $314.60 Million |
| Current Assets | $645.82 Million |
| Liabilities And Equity | $931.45 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||